Justera Health Ltd.
SCRSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 0.01 | 0.02 | -0.00 |
| FCF Yield | 179.00% | -48.30% | -14.24% | -12.25% |
| EV / EBITDA | -0.15 | -0.70 | -2.83 | -3.28 |
| Quality | ||||
| ROIC | 69.64% | 5,641.03% | -285.58% | -317.19% |
| Gross Margin | 62.86% | 44.75% | 17.56% | -1.52% |
| Cash Conversion Ratio | -0.10 | 0.27 | 0.20 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | -54.10% | -55.27% | – | – |
| Free Cash Flow Growth | 139.48% | 10.80% | 10.00% | -6,956.55% |
| Safety | ||||
| Net Debt / EBITDA | -0.05 | -0.07 | 0.11 | 0.02 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 10.36 | 10.80 | 26.21 | 9.42 |
| Cash Conversion Cycle | -3,162.96 | -255.25 | -91.34 | -26.26 |